Market Overview:
The global vitamin E nicotinate market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising awareness about the benefits of vitamin E nicotinate, and growing demand for natural ingredients in dietary supplements. The global vitamin E nicotinate market is segmented on the basis of type, application, and region. On the basis of type, it is divided into above 97% purity and 97% purity segments. The above 97% purity segment is expected to account for a larger share of the global market than the 97% purity segment during the forecast period owing to its higher efficacy and better safety profile as compared with other types of vitamin E nicotinates available in the market. On the basis of application, it is classified into vascular disorders and abnormal lipid metabolism segments.
Product Definition:
A water soluble form of vitamin E that is used to treat vitamin E deficiency.
Above 97.0% Purity:
97% or more purity vitamin E is also known as super vitamin E. It's a fat-soluble antioxidant and helps to maintain the health of cells, DNA synthesis, and RNA transcription. Vitamin E supplements are usually taken daily by mouth for prevention from heart disease, cancer & diabetes along with treatment of the same conditions.
97.0% Purity:
97% purity is a form of vitamin E. It is used in Vitamin E Nicotinate, which is a nicotine replacement therapy for smoking cessation. 97% purity has been tested and found to be free from any contaminants or impurities.
Application Insights:
The global vitamin E nicotinate market is segmented on the basis of application into vascular disorders, abnormal lipid metabolism and other applications. The other applications include nutritional supplements & medicines. The abnormal lipid metabolism segment held the largest share in 2017 owing to increasing prevalence of cardiovascular diseases and rising awareness about preventive measures against such diseases among consumers, healthcare professionals and food manufacturers.
Vascular disorders are expected to be one of the fastest-growing segments over the forecast period due to rising incidence rate of stroke globally coupled with a rise in demand for effective treatment options that help reduce blood pressure levels as well as cholesterol levels. According to WHO, around 1 in 3 deaths occur due to cardiovascular disease worldwide while according to CDC around 742,000 die from it every year in U.S.
Regional Analysis:
North America was the largest market for vitamin E nicotinate in 2017. The region is expected to witness a CAGR of XX% over the forecast period owing to high consumption of dietary supplements and increasing prevalence of cardiovascular diseases, diabetes, and cancer in U.S., which are major applications for this product.
Growth Factors:
- Increasing awareness about the benefits of Vitamin E Nicotinate among consumers.
- Rising demand for natural and organic personal care products.
- Growing popularity of vitamin supplements among health-conscious consumers.
- Proliferation of online retail channels that offer a wide range of vitamin E nicotinate products at competitive prices.
Scope Of The Report
Report Attributes
Report Details
Report Title
Vitamin E Nicotinate Market Research Report
By Type
Above 97.0% Purity, 97.0% Purity
By Application
Vascular Disorders, Abnormal Lipid Metabolism
By Companies
TRI-K Industries, Zhejiang Kinglyuan Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Vitamin E Nicotinate Market Report Segments:
The global Vitamin E Nicotinate market is segmented on the basis of:
Types
Above 97.0% Purity, 97.0% Purity
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Vascular Disorders, Abnormal Lipid Metabolism
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- TRI-K Industries
- Zhejiang Kinglyuan Pharmaceutical
Highlights of The Vitamin E Nicotinate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Above 97.0% Purity
- 97.0% Purity
- By Application:
- Vascular Disorders
- Abnormal Lipid Metabolism
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vitamin E Nicotinate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vitamin E Nicotinate is a form of Vitamin E that has been chemically altered so that it can be absorbed into the body more easily.
Some of the major players in the vitamin e nicotinate market are TRI-K Industries, Zhejiang Kinglyuan Pharmaceutical.
The vitamin e nicotinate market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Vitamin E Nicotinate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Vitamin E Nicotinate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Vitamin E Nicotinate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Vitamin E Nicotinate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Vitamin E Nicotinate Market Size & Forecast, 2020-2028
4.5.1 Vitamin E Nicotinate Market Size and Y-o-Y Growth
4.5.2 Vitamin E Nicotinate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Above 97.0% Purity
5.2.2 97.0% Purity
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Vascular Disorders
6.2.2 Abnormal Lipid Metabolism
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Vitamin E Nicotinate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Vitamin E Nicotinate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Above 97.0% Purity
9.6.2 97.0% Purity
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Vascular Disorders
9.10.2 Abnormal Lipid Metabolism
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Above 97.0% Purity
10.6.2 97.0% Purity
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Vascular Disorders
10.10.2 Abnormal Lipid Metabolism
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Above 97.0% Purity
11.6.2 97.0% Purity
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Vascular Disorders
11.10.2 Abnormal Lipid Metabolism
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Above 97.0% Purity
12.6.2 97.0% Purity
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Vascular Disorders
12.10.2 Abnormal Lipid Metabolism
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Above 97.0% Purity
13.6.2 97.0% Purity
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Vascular Disorders
13.10.2 Abnormal Lipid Metabolism
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Vitamin E Nicotinate Market: Competitive Dashboard
14.2 Global Vitamin E Nicotinate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 TRI-K Industries
14.3.2 Zhejiang Kinglyuan Pharmaceutical
